Abstract Despite national efforts to reduce lead exposure, some children are still exposed to lead, leading to damage to the nervous system, delayed development, and learning and behavioral problems. CDC has recommended targeting high-risk groups for screening. In addition, Texas Department of State Health Services reported a concerning 17% lead testing coverage of 0-to-5-year-olds in in Harris County (where Houston is located). With the eventual goal of improving lead-related clinical care in a large pediatric hospital network, we asked the following questions: 1) What are the high-risk groups specific to our patient population? 2) For patients who are screened positive, are we adequately confirming the results? 3) For those with confirmed lead exposure, are we providing adequate follow-up care? To answer these questions, we analyzed lead testing and hemoglobin testing data on all children less than 6 years of age from the Texas Children’s Hospital’s electronic health record between 2017 and 2021. Lead screening could be performed on capillary or venous blood, but for elevations on capillary blood we analyzed if the results were confirmed with a venous blood test, as recommended by CDC. We used hemoglobin testing as an indicator of follow-up care of lead-exposed children, because an anemia work-up is recommended for such children. We repeated analysis using two different lead level thresholds, because of recent change to the CDC blood lead reference value from 5 mcg/dL to 3.5 mcg/dL in May 2021. We found 273 children (0.33% of children with capillary blood test) to have cBLL = 3.5mcg/dL. There was a significant racial disparity in the rate of lead screening. For example, the screening rate of Black children was 14%, whereas that of White children were 23%. There was a geographic discrepancy between the areas with most elevated cBLL and testing volume. For example, the area where cBLL was most frequently elevated (3.7%) received less than a fifth of tests compared to the most well-tested area. Only 75% of children with a cBLL = 5mcg/dL received a timely venous blood lead test for confirmation, and this dropped to 43% for children with a cBLL = 3.5mcg/dL. Similarly, only 75% of children with a confirmed venous lead level = 5 mcg/dL received a follow-up repeat vBLL test, and 55% received a follow-up hemoglobin measurement. There is room for improvement in population lead health, in terms of both equity and resource distribution. Improvement of lead-related clinical practice could benefit hundreds of children in the Houston metropolitan area.
Read full abstract